Carbiotix (publ) announced that the company has hired Dr. Richard A. Rosenbloom as its new chief medical officer (CMO). Richard has been an advisor to the company since 2019 and starting in May will assist the company with CMO duties, product development, regulatory affairs, pharmacovigilance, safety and medical affairs. Richard has decades of experience working in the United States as a CMO, Medical Director and Director of Medical Affairs for both pharmaceutical and clinical research companies.

As the new CMO, Richard will support the company's activities regarding the market launch of CarbiAXOS and ramping up the efforts concerning medical food co-interventions and therapeutic co-treatments.